% ============================================================================
% CONSTRAINT STORY: alzheimers_nlrp3_inflammasome
% ============================================================================
% Version: 1.0 (Deferential Realism Core + Directionality + Boltzmann + Network)
% Logic: 6.0 (Indexed Tuple P,T,E,S + Sigmoid f(d) + Coupling + Purity + Network)
% Generated: 2024-02-29
% Status: [ACTIVE]
% ============================================================================

:- module(constraint_alzheimers_nlrp3_inflammasome, []).

:- use_module(constraint_indexing).
:- use_module(domain_priors).
:- use_module(narrative_ontology).

% --- Constraint Identity Rule (DP-001: ε-Invariance) ---
% Each constraint story must have a single, stable base extractiveness (ε).
% If changing the observable used to evaluate this constraint would change ε,
% you are looking at two distinct constraints. Write separate .pl files for
% each, link them with affects_constraint/2, and document the relationship
% in both files' narrative context sections.
%
% The context tuple is CLOSED at arity 4: (P, T, E, S).
% Do not add measurement_basis, beneficiary/victim, or any other arguments.
% Linter Rule 23 enforces context/4.
%
% See: epsilon_invariance_principle.md

% --- Namespace Hooks (Required for loading) ---
:- multifile
    domain_priors:base_extractiveness/2,
    domain_priors:suppression_score/2,
    domain_priors:theater_ratio/2,
    domain_priors:requires_active_enforcement/1,
    narrative_ontology:has_sunset_clause/1,
    narrative_ontology:interval/3,
    narrative_ontology:measurement/5,
    narrative_ontology:constraint_metric/3,
    narrative_ontology:constraint_beneficiary/2,
    narrative_ontology:constraint_victim/2,
    narrative_ontology:constraint_claim/2,
    narrative_ontology:coordination_type/2,
    constraint_indexing:constraint_classification/3,
    narrative_ontology:omega_variable/3,
    narrative_ontology:human_readable/2,
    narrative_ontology:topic_domain/2.

/* ==========================================================================
   1. NARRATIVE CONTEXT
   ========================================================================== */

/**
 * CONSTRAINT IDENTIFICATION
 *   constraint_id: alzheimers_nlrp3_inflammasome
 *   human_readable: Alzheimer's Disease Pathogenesis via NLRP3 Inflammasome
 *   domain: technological
 *
 * SUMMARY:
 *   The NLRP3 inflammasome pathway is implicated in the pathogenesis of
 *   Alzheimer's disease, presenting a potential therapeutic target. This
 *   constraint models the dynamics between pharmaceutical companies, research
 *   institutions, Alzheimer's patients, and caregivers. The pathway, while
 *   offering potential benefits, also presents extractive aspects. Success
 *   attracts funding and generates revenue, but the benefit flow depends on
 *   therapeutic efficacy and accessibility. Without effective therapies, the
 *   scientific effort remains primarily extractive.
 *
 * KEY AGENTS:
 *   - Alzheimer's Patients: Primary target (powerless/trapped) - bear the cost of the disease progression.
 *   - Caregivers: Secondary target (moderate/constrained) - bear emotional and financial burdens.
 *   - Pharmaceutical Companies: Primary beneficiary (institutional/arbitrage) - benefit from development/sales of therapies.
 *   - Research Institutions: Secondary beneficiary (institutional/arbitrage) - benefit from funding and publications.
 */

/* ==========================================================================
   2. BASE PROPERTIES (DOMAIN PRIORS)
   ========================================================================== */

% --- Numerical metrics ---
domain_priors:base_extractiveness(alzheimers_nlrp3_inflammasome, 0.55).
domain_priors:suppression_score(alzheimers_nlrp3_inflammasome, 0.4).
domain_priors:theater_ratio(alzheimers_nlrp3_inflammasome, 0.2).

% --- Constraint metric facts (engine primary keys, must mirror domain_priors) ---
narrative_ontology:constraint_metric(alzheimers_nlrp3_inflammasome, extractiveness, 0.55).
narrative_ontology:constraint_metric(alzheimers_nlrp3_inflammasome, suppression_requirement, 0.4).
narrative_ontology:constraint_metric(alzheimers_nlrp3_inflammasome, theater_ratio, 0.2).

% --- Constraint claim ---
narrative_ontology:constraint_claim(alzheimers_nlrp3_inflammasome, tangled_rope).
narrative_ontology:human_readable(alzheimers_nlrp3_inflammasome, "Alzheimer's Disease Pathogenesis via NLRP3 Inflammasome").
narrative_ontology:topic_domain(alzheimers_nlrp3_inflammasome, "technological").

domain_priors:requires_active_enforcement(alzheimers_nlrp3_inflammasome).

% --- Structural relationships ---
narrative_ontology:constraint_beneficiary(alzheimers_nlrp3_inflammasome, pharmaceutical_companies).
narrative_ontology:constraint_beneficiary(alzheimers_nlrp3_inflammasome, research_institutions).
narrative_ontology:constraint_victim(alzheimers_nlrp3_inflammasome, alzheimer_patients).
narrative_ontology:constraint_victim(alzheimers_nlrp3_inflammasome, caregivers).

/* ==========================================================================
   3. INDEXED CLASSIFICATIONS (P, T, E, S)
   ========================================================================== */

% Perspective of Alzheimer's patients who are trapped by the disease progression and its associated cognitive decline, bearing the full cost of the pathogenic mechanism without an effective exit.
constraint_indexing:constraint_classification(alzheimers_nlrp3_inflammasome, snare,
    context(agent_power(powerless),
            time_horizon(generational),
            exit_options(trapped),
            spatial_scope(global))).

% Caregivers are constrained by the demands of caring for Alzheimer's patients, facing emotional, financial, and physical burdens. They benefit from potential therapeutic advancements but also bear the costs of the disease's impact.
constraint_indexing:constraint_classification(alzheimers_nlrp3_inflammasome, tangled_rope,
    context(agent_power(moderate),
            time_horizon(biographical),
            exit_options(constrained),
            spatial_scope(global))).

% Pharmaceutical companies benefit from developing and marketing therapies targeting the NLRP3 inflammasome pathway in Alzheimer's disease. They have arbitrage opportunities in the market but also face risks associated with clinical trial failures and regulatory hurdles.
constraint_indexing:constraint_classification(alzheimers_nlrp3_inflammasome, rope,
    context(agent_power(institutional),
            time_horizon(generational),
            exit_options(arbitrage),
            spatial_scope(global))).

% Research institutions benefit from funding and recognition for studying the NLRP3 inflammasome pathway in Alzheimer's disease. They have arbitrage opportunities in securing grants and publishing research but also face challenges in translating findings into effective therapies.
constraint_indexing:constraint_classification(alzheimers_nlrp3_inflammasome, rope,
    context(agent_power(institutional),
            time_horizon(generational),
            exit_options(arbitrage),
            spatial_scope(global))).

% The analytical observer, with a civilizational perspective, recognizes the mixed coordination and extraction inherent in the NLRP3 inflammasome pathway's role in Alzheimer's disease pathogenesis. It represents both a target for therapeutic intervention and a source of potential exploitation.
constraint_indexing:constraint_classification(alzheimers_nlrp3_inflammasome, tangled_rope,
    context(agent_power(analytical),
            time_horizon(civilizational),
            exit_options(analytical),
            spatial_scope(global))).

/* ==========================================================================
   4. VALIDATION TESTS
   ========================================================================== */

:- begin_tests(alzheimers_nlrp3_inflammasome_tests).

test(perspectival_gap) :-
    constraint_indexing:constraint_classification(alzheimers_nlrp3_inflammasome, TypePowerless, context(agent_power(powerless), _, _, _)),
    constraint_indexing:constraint_classification(alzheimers_nlrp3_inflammasome, TypeOther, context(agent_power(moderate), _, _, _)),
    TypePowerless \= TypeOther.

test(extraction_signature) :-
    domain_priors:base_extractiveness(alzheimers_nlrp3_inflammasome, E),
    E >= 0.46. % Ensures high-extraction Snare/Tangled territory.

:- end_tests(alzheimers_nlrp3_inflammasome_tests).

/* ==========================================================================
   5. GENERATIVE COMMENTARY
   ========================================================================== */

/**
 * LOGIC RATIONALE:
 *   Extractiveness (0.55): The pathway itself extracts resources from research and therapeutic development. Suppression (0.40): Limited access to effective therapies and high cost of research. Theater Ratio (0.20): Relatively low, as research focuses on genuine mechanism, not theatrical posturing.
 *
 * PERSPECTIVAL GAP:
 *   Patients see the pathway as a snare, trapping them within the disease. Caregivers experience constrained burden but potential benefit from therapies. Companies and institutions view the pathway as a source of revenue and recognition. The Analytical observer views the interplay of coordination and extraction.
 *
 * DIRECTIONALITY LOGIC:
 *   Pharmaceutical companies and research institutions, with their ability to arbitrage the market and influence research funding, benefit from this mechanism. Alzheimer's patients and caregivers, trapped by the disease and constrained by limited resources, bear the burden of extraction.
 *
 */

/* ==========================================================================
   6. OMEGA VARIABLES (Ω) - IRREDUCIBLE UNCERTAINTIES
   ========================================================================== */

omega_variable(
    therapeutic_target_specificity,
    'Is the NLRP3 inflammasome pathway a specific and effective therapeutic target for Alzheimer''s disease, or does it have broader implications for other inflammatory conditions?',
    'Clinical trials assessing the efficacy and safety of NLRP3 inhibitors in Alzheimer''s patients, coupled with mechanistic studies elucidating the pathway''s role in the disease.',
    'If specific: targeted therapies will be more effective and have fewer side effects. If broader: potential for off-target effects and limited efficacy.',
    confidence_without_resolution(medium)
).

narrative_ontology:omega_variable(therapeutic_target_specificity, empirical, 'Specificity of NLRP3 inflammasome as therapeutic target').

omega_variable(
    disease_stage_relevance,
    'Is the NLRP3 inflammasome pathway more relevant in early or late stages of Alzheimer''s disease, influencing the timing of therapeutic interventions?',
    'Longitudinal studies correlating NLRP3 inflammasome activity with disease progression and cognitive decline, as well as clinical trials testing the efficacy of interventions at different stages.',
    'If early: preventative strategies targeting the pathway may be more effective. If late: interventions aimed at reducing inflammation and slowing disease progression may be more beneficial.',
    confidence_without_resolution(medium)
).

narrative_ontology:omega_variable(disease_stage_relevance, empirical, 'Relevance of NLRP3 inflammasome to disease stage').


/* ==========================================================================
   7. INTEGRATION HOOKS
   ========================================================================== */

narrative_ontology:interval(alzheimers_nlrp3_inflammasome, 0, 10).

/* ==========================================================================
   8. TEMPORAL MEASUREMENTS (LIFECYCLE DRIFT DATA)
   ========================================================================== */

% Theater ratio over time
narrative_ontology:measurement(alzh_tr_t0, alzheimers_nlrp3_inflammasome, theater_ratio, 0, 0.1).
narrative_ontology:measurement(alzh_tr_t5, alzheimers_nlrp3_inflammasome, theater_ratio, 5, 0.2).
narrative_ontology:measurement(alzh_tr_t10, alzheimers_nlrp3_inflammasome, theater_ratio, 10, 0.3).

% Extraction over time
narrative_ontology:measurement(alzh_be_t0, alzheimers_nlrp3_inflammasome, base_extractiveness, 0, 0.4).
narrative_ontology:measurement(alzh_be_t5, alzheimers_nlrp3_inflammasome, base_extractiveness, 5, 0.55).
narrative_ontology:measurement(alzh_be_t10, alzheimers_nlrp3_inflammasome, base_extractiveness, 10, 0.65).


/* ==========================================================================
   9. BOLTZMANN & NETWORK DATA
   ========================================================================== */

narrative_ontology:coordination_type(alzheimers_nlrp3_inflammasome, resource_allocation).

/* ==========================================================================
   10. DIRECTIONALITY OVERRIDES (v6.0, OPTIONAL)
   ========================================================================== */

/* ==========================================================================
   END OF CONSTRAINT STORY
   ========================================================================== */
